Q8
(a) (i) Summarise the spectrum of Iodine Deficiency Disorders. (10 marks) (ii) State the goal, objectives and salient features of Iodine Deficiency Disorder Control Programme. (10 marks) (b) (i) What are the major changes that have been introduced under the MTP (Amendment) Act, 2021? (6 marks) (ii) What are the different contraceptive methods employed by people in India? List them in the order of their usage stating the statistics of how commonly they are used. (5 marks) (iii) What measures can help increase the use of contraceptives in India? (4 marks) (c) A 47-year-old female presents to the surgery OPD with a solitary nodule in the right lobe of thyroid gland. (i) How will you investigate this case? (5 marks) (ii) What is the ideal treatment if investigations are suggestive of follicular neoplasm? (5 marks) (iii) How will you follow-up a patient who has undergone total thyroidectomy for papillary carcinoma thyroid 5 days back? (5 marks)
हिंदी में प्रश्न पढ़ें
(a) (i) आयोडीन अल्पता से होने वाले विकारों के स्पेक्ट्रम का सारांश प्रस्तुत कीजिए । (10 अंक) (ii) आयोडीन अल्पता विकार नियंत्रण कार्यक्रम (आयोडीन डेफिशिएंसी डिसऑर्डर कंट्रोल प्रोग्राम) के ध्येय (गोल), लक्ष्य (ऑब्जेक्टिव्स) तथा मुख्य विशेषताओं की संक्षेप में चर्चा कीजिए । (10 अंक) (b) (i) एम.टी.पी. (संशोधन) अधिनियम, 2021 के अंतर्गत क्या-क्या प्रमुख परिवर्तन लाए गए हैं ? (6 अंक) (ii) भारत में लोग कौन-कौन से गर्भनिरोधक उपाय व्यवहार में लाते हैं ? उनके उपयोग के आधार पर उन्हें क्रम से गिनाइए और उनके प्रचलन के आँकड़े बताइए । (5 अंक) (iii) कौन-कौन से उपाय भारत में गर्भनिरोधकों के प्रचलन को बढ़ावा देने में उपयोगी सिद्ध हो सकते हैं ? (4 अंक) (c) अवटु ग्रंथि के दक्षिण खंड में एकल पर्विका होने के कारण एक 47-वर्षीय महिला शल्योपचार (सर्जरी) ओ.पी.डी. में अपने उपचार के लिए आती है । (i) इस रोगी की जाँच आप कैसे करेंगे ? (5 अंक) (ii) यदि जाँच करने पर पुटकीय अर्बुद होने के संकेत मिलें, तो सर्वथा उपयुक्त उपचार क्या होगा ? (5 अंक) (iii) एक रोगी जिसका 5 दिन पूर्व अवटु ग्रंथि के पैपिलरी कार्सिनोमा के लिए संपूर्ण अवटु-उच्छेदन किया गया था, उसका फोलो-अप आप कैसे करेंगे ? (5 अंक)
Directive word: Describe
This question asks you to describe. The directive word signals the depth of analysis expected, the structure of your answer, and the weight of evidence you must bring.
See our UPSC directive words guide for a full breakdown of how to respond to each command word.
How this answer will be evaluated
Approach
This multi-part descriptive question requires systematic coverage of public health (40%), legal/ demographic (30%), and clinical surgical (30%) components. Begin with a brief introduction acknowledging iodine deficiency as India's historically significant public health problem, then proceed part-wise: (a) requires structured enumeration of IDD spectrum and programme details with NIDDCP/NNM references; (b) demands precise legal changes from MTP Amendment 2021, contraceptive hierarchy per NFHS-5 data, and evidence-based demand-generation strategies; (c) needs algorithmic clinical reasoning for thyroid nodule workup, surgical decision-making for follicular neoplasm, and post-thyroidectomy follow-up protocol. Conclude with integrative remark on preventive-to-curative continuum in endocrine care.
Key points expected
- (a)(i) Spectrum of IDD: Goitre (diffuse/nodular), hypothyroidism, cretinism (neurological/myxedematous), endemic cretinism, stillbirths, impaired mental function, iodine-induced hyperthyroidism (Jod-Basedow)
- (a)(ii) NIDDCP/NNM goals: Universal salt iodization (USI), <5% endemic goitre, objectives of eliminating IDD by 2020, salient features of IDDCP including NIDDCP 1992, NNM 2018, double fortified salt, monitoring through urinary iodine estimation
- (b)(i) MTP Amendment 2021: Extension to 24 weeks for special categories, removal of marital status requirement, confidentiality clause, registered medical practitioner definition, gestation-based categorization, board constitution for >24 weeks
- (b)(ii) Contraceptive hierarchy per NFHS-5: Female sterilization (37.9%), male sterilization (0.3%), IUD (2.1%), OCPs (2.4%), condoms (9.5%), traditional methods (5.1%), any modern method (56.5%)
- (b)(iii) Demand generation: ASHA counseling, male involvement, social marketing, postpartum/post-abortion family planning integration, removal of method-specific targets, community-based distribution
- (c)(i) Thyroid nodule investigation: TSH, T4, ultrasound (TI-RADS), FNAC (Bethesda system), serum calcitonin if MEN2 suspected, TPO antibodies, radionuclide scan if TSH low
- (c)(ii) Follicular neoplasm management: Hemithyroidectomy/lobectomy as diagnostic and therapeutic, intraoperative frozen section, completion thyroidectomy if invasive cancer confirmed, avoid total thyroidectomy upfront due to benign majority
- (c)(iii) Post-total thyroidectomy follow-up: Calcium and PTH monitoring for hypoparathyroidism, thyroglobulin as tumor marker, TSH suppression with levothyroxine, radioactive iodine ablation planning, laryngeal nerve function assessment
Evaluation rubric
| Dimension | Weight | Max marks | Excellent | Average | Poor |
|---|---|---|---|---|---|
| Concept correctness | 20% | 10 | Accurately defines all IDD entities with correct pathophysiology; precisely states MTP 2021 amendments with section numbers; correctly identifies Bethesda III/IV management for follicular neoplasm; cites NFHS-5 contraceptive prevalence rates accurately | Lists major IDD conditions but confuses neurological/myxedematous cretinism features; states MTP amendments generally without specificity; knows hemithyroidectomy for follicular neoplasm but unclear on frozen section role; contraceptive statistics approximate or outdated | Confuses IDD with other micronutrient deficiencies; misstates MTP gestational limits or marital clause removal; recommends total thyroidectomy upfront for follicular neoplasm; invents contraceptive statistics or omits NFHS data entirely |
| Clinical correlation | 20% | 10 | Links IDD spectrum to age-specific vulnerability (fetal, neonatal, school-age, adult); correlates MTP amendments with maternal mortality reduction goals; applies TI-RADS and Bethesda systems appropriately to 47-year-old nodule; anticipates hypoparathyroidism risk post-total thyroidectomy | Mentions vulnerable groups for IDD without developmental impact detail; states MTP changes without public health rationale; performs standard nodule workup without risk stratification; lists follow-up parameters without prioritization | Treats IDD as only goitre problem; discusses MTP as isolated legal change without health system context; omits TSH or ultrasound in nodule workup; ignores calcium monitoring in post-operative follow-up |
| Diagram / pathway | 15% | 7.5 | Includes thyroid hormone synthesis pathway diagram for IDD pathophysiology; draws algorithm for thyroid nodule investigation (TSH → ultrasound → FNAC → management); presents contraceptive method mix pyramid with NFHS-5 proportions | Mentions need for diagrams but execution incomplete; describes nodule algorithm textually without visual; lists contraceptives without graphical representation of usage hierarchy | No diagrams or flowcharts despite clear opportunities; disorganized presentation without algorithmic structure; omits visual representation entirely |
| Differential / staging | 20% | 10 | Differentiates follicular adenoma from carcinoma (vascular/capsular invasion); distinguishes Bethesda categories I-VI with management implications; contrasts papillary carcinoma follow-up (TNM staging awareness) with follicular neoplasm approach; differentiates primary from secondary IDD | States follicular neoplasm is indeterminate without explaining diagnostic dilemma; mentions Bethesda system without category-specific actions; lists follow-up generally without staging context | Fails to distinguish follicular adenoma from carcinoma; omits Bethesda classification entirely; no differentiation of benign from malignant nodule management; confuses IDD etiologies |
| Management / public-health angle | 25% | 12.5 | Comprehensive IDDCP/NNM strategy with USI, monitoring, sustainability; evidence-based contraceptive demand generation citing Mission Parivar Vikas; optimal surgical approach for follicular neoplasm with intraoperative decision-making; structured post-thyroidectomy surveillance including thyroglobulin and RAI planning | Lists IDD programme components without integration; contraceptive measures generic without targeting high-fertility states; surgical management stated without nuance; follow-up incomplete regarding TSH suppression targets | Omits NIDDCP/NNM entirely; contraceptive suggestions unrealistic or coercive; inappropriate total thyroidectomy for follicular neoplasm; dangerous omission of calcium monitoring post-surgery |
Practice this exact question
Write your answer, then get a detailed evaluation from our AI trained on UPSC's answer-writing standards. Free first evaluation — no signup needed to start.
Evaluate my answer →More from Medical Science 2021 Paper II
- Q1 (a) Discuss in brief the role of ultrasound in the investigation of pain in right hypochondrium. (10 marks) (b) Outline the pharmacological…
- Q2 (a) A sixty-year-old diabetic male presented to the emergency department with acute onset, central squeezing type of chest pain, which is s…
- Q3 (a) A 40-year-old male who was bedridden for the last two months following a fracture in the lower limb developed sudden breathlessness. (i…
- Q4 (a) Discuss in short the etiology, diagnosis, treatment and complications of cirrhosis of liver. (5+5+5+5=20 marks) (b) A 15-month-old chil…
- Q5 (a) Briefly describe the clinical features, diagnostic workup and management of a patient of choledochal cyst. (3+4+3=10 marks) (b) A 60-ye…
- Q6 (a) (i) Write in brief the reasons for rising Caesarean Section rates globally and in India. (5 marks) (ii) Discuss briefly the advantages…
- Q7 (a) A 60-year-old male presents with progressively increasing jaundice for 2 months. He is having clay coloured stools and pruritus. On exa…
- Q8 (a) (i) Summarise the spectrum of Iodine Deficiency Disorders. (10 marks) (ii) State the goal, objectives and salient features of Iodine De…